Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA's Gottlieb: 'Pricing And Reimbursement Mischief' Holding Back Biosimilar Market

Mar 08 2018

• By Jessica Merrill

Commissioner Gottlieb speaking at RAPS 2017

Related Content

Payers Could Guarantee Biosimilar Market Share, FDA's Gottlieb Suggests

Sep 22 2017

Pfizer Sets The Stage For A Biosimilar Showdown Over Exclusive Contracts

Sep 20 2017

Payers Like Biosimilars, But Rebates Remain The Bottom Line (For Now)

Nov 29 2017

Related Companies

Johnson & Johnson

Pfizer Inc.

Celltrion, Inc.

Merck & Co., Inc.

Samsung Bioepis Co., Ltd.

Novartis AG

Amgen, Inc.

Teva Pharmaceutical Industries Ltd.

Additional Topics

United States Biosimilars Pricing Debate FDA Commercial Policy BioPharmaceutical

More from Drug Pricing

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window